More News

30 Mar 2017 Daiichi Sankyo Announces Collaborative Research on Drugs for Neglected Tropical Diseases
30 Mar 2017 Vanda and UCSF Announce License Agreement for CFTR Activators and Inhibitors
30 Mar 2017 Chugai - A*STAR Joint Development Project for Anti-Dengue Virus Antibody Selected as Grant Recipient by the GHIT Fund
30 Mar 2017 Merck KGaA, Darmstadt, Germany Advances R&D Strategy through Unique Development Model with Avillion for Anti IL-17 A/F Nanobody®
29 Mar 2017 Warp Drive Bio Forms Technology Alliance with GSK to Discover Potential Therapeutics in Oncology and Other Diseases
29 Mar 2017 Mitsubishi Tanabe Pharma and Daiichi Sankyo to Expand Strategic Alliance in the Diabetes Field
28 Mar 2017 Immune-Onc Therapeutics, Inc. Announces Licensing and Collaboration With Albert Einstein College of Medicine and Memorial Sloan Kettering Cancer Center to Develop Novel Cancer Immunotherapy
28 Mar 2017 Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and the Cancer Research Institute Announce Collaboration to Accelerate Immuno-Oncology Research
28 Mar 2017 Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24
28 Mar 2017 Numab and Ono Pharmaceutical Co., Ltd. Enter into a Research and Option Agreement
24 Mar 2017 PureTech Health Announces Licensing and Equity Agreement with Novartis to Advance Clinical Stage mTORC1 Programs
24 Mar 2017 C4 Therapeutics and Calico Enter Strategic Partnership to Discover Novel Therapeutics Based on Targeted Protein Degradation
24 Mar 2017 BioLineRx Announces Acquisition of Agalimmune Ltd. to Accelerate Expansion of Immuno-Oncology Pipeline
24 Mar 2017 Tessa Therapeutics Announces Acquisition of Euchloe Bio
21 Mar 2017 X-Chem and Ono Enter into Multi-Target Drug Discovery Collaboration
21 Mar 2017 Pierre Fabre and H-Immune Announce Strategic Research Partnership to Develop Potentially Ground-Breaking Cancer Immunotherapies
20 Mar 2017 X-Chem Announces Strategic Collaboration with Astellas Pharma Across Multiple Therapeutic Areas
20 Mar 2017 Bristol-Myers Squibb and CytomX Therapeutics Extend Worldwide Collaboration to Discover Probody™ Therapeutics for the Treatment of Cancer and Other Diseases
17 Mar 2017 Threshold Pharmaceuticals and Molecular Templates Agree to Combine
17 Mar 2017 Provecs Medical closes immuno-oncology collaboration with Medac
17 Mar 2017 BELLUS Health Announces the Sale of Subsidiary Thallion Pharmaceuticals to Taro Pharmaceuticals
17 Mar 2017 AstraZeneca and Circassia enter strategic collaboration in respiratory disease
16 Mar 2017 Medicenna BioPharma Announces Strategic Collaboration with MD Anderson Cancer Center to Advance Next Generation Empowered Cytokines
14 Mar 2017 Vedantra Pharmaceuticals Announces a Joint Research Collaboration with Neon Therapeutics to Develop Cancer Vaccines
14 Mar 2017 Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing